The Danger of ‘Invisible’ Biolabs Across the U.S.

Audio versions of blogs and papers from BlueDot courses.

As synthetic biology techniques develop and the barriers to entry become lower, we are increasingly seeing the development of privately-operated biological labs. These often enforce less stringent safety standards than those in academia, and can fall through the cracks of regulatory oversight. This article focuses on a recent example in California, emphasising the need for a unified regulatory system and increased federal oversight for these labs, especially those working with dangerous pathogens.

Original text:
https://time.com/6309643/invisible-biolabs/

Author(s):
Dan Greene and Jassi Pannu and Allison Berke

A podcast by BlueDot Impact.